Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Abivax (ABVX) Profit After Tax (2022 - 2025)

Historic Profit After Tax for Abivax (ABVX) over the last 3 years, with Q3 2025 value amounting to -$297.1 million.

  • Abivax's Profit After Tax fell 58985.87% to -$297.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$297.1 million, marking a year-over-year change of. This contributed to the annual value of -$188.3 million for FY2024, which is 1784.49% down from last year.
  • As of Q3 2025, Abivax's Profit After Tax stood at -$297.1 million, which was down 58985.87% from -$114.1 million recorded in Q2 2025.
  • Abivax's 5-year Profit After Tax high stood at $60.7 million for Q3 2024, and its period low was -$334.6 million during Q4 2024.
  • In the last 3 years, Abivax's Profit After Tax had a median value of -$36.2 million in 2025 and averaged -$87.6 million.
  • The largest annual percentage gain for Abivax's Profit After Tax in the last 5 years was 1829.13% (2025), contrasted with its biggest fall of 58985.87% (2025).
  • Abivax's Profit After Tax (Quarter) stood at -$159.0 million in 2023, then crashed by 110.48% to -$334.6 million in 2024, then rose by 11.2% to -$297.1 million in 2025.
  • Its Profit After Tax was -$297.1 million in Q3 2025, compared to -$114.1 million in Q2 2025 and $55.1 million in Q1 2025.